Fuente: https://nida.nih.gov/es/download/20630/el-fentanilo-drugfacts.pdf El fentanilo es un fuerte opioide sintético similar a la morfina, pero entre 50 y 100 veces más potente. Es un fármaco recetado que a veces también se usa en forma ilegal. Al igual que la morfina, por lo general se receta a...

Source: National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services. Fentanyl is a powerful synthetic opioid that is similar to morphine but is 50 to 100 times more potent. It is a prescription drug that is also made and used illegally. Like morphine...

Source: Snowdon, J., & Choi, N. (2022). Unanticipated Changes in Drug Overdose Death Rates in Canada During the Opioid Crisis. International journal of mental health and addiction, 1–19. Advance online publication. https://doi.org/10.1007/s11469-022-00932-9

Source: Marel, C., Wilson, J., Darke, S., Ross, J., Slade, T., Haber, P. S., Haasnoot, K., Visontay, R., Keaveny, M., Tremonti, C., Mills, K. L., & Teesson, M. (2023). Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the...

Source: https://store.samhsa.gov/sites/default/files/pep23-02-01-002.pdf This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of...

Source: Taylor EA, Cantor JH, Bradford AC, Simon K, Stein BD. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes. JAMA Netw Open. 2023;6(5):e2314328. doi:10.1001/jamanetworkopen.2023.14328 Key Points Question Did rates of methadone dispensing for opioid use...

Source: Jakubowski, A., Singh-Tan, S., Torres-Lockhart, K. et al. Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. Addict Sci Clin Pract 18, 31 (2023). https://doi.org/10.1186/s13722-023-00386-x Abstract...

Source: Hooker, S. A., Crain, A. L., LaFrance, A. B., Kane, S., Fokuo, J. K., Bart, G., & Rossom, R. C. (2023). A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians. Addiction Science & Clinical Practice, 18(1), 1-10...

Source: Washburn LT, Franck KL, Upendram S and Yenerall JN (2022) Cooperative Extension professionals’ knowledge and attitudes toward the opioid epidemic: Implications for capacity development and outreach. Front. Psychiatry 13:958335. doi: 10.3389/fpsyt.2022.958335 Introduction: Worsening of the...

Source: Dolan AR, Goldberg EB, Cannuscio CC, et al. Patient Perceptions About Opioid Risk Communications Within the Context of a Randomized Clinical Trial. JAMA Netw Open. 2022;5(8):e2227650. doi:10.1001/jamanetworkopen.2022.27650 Key Points Question What can be learned about patient experiences...

Source: Beaudoin FL, Jacka BP, Li Y, et al. Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(8):e2225582. doi:10.1001/jamanetworkopen.2022.25582 Key Points Question Can peer-led...

Source: Andraka-Christou, B., Page, C., Schoebel, V. et al. Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants. Addict Sci Clin Pract 17, 43 (2022). https://doi.org/10.1186/s13722-022-00321-6 Abstract Background Medications for opioid use disorder...

Source: Hodgins, D. C., Budd, M., Czukar, G., Dubreucq, S., Jackson, L. A., Rush, B., ... & Cameron Wild, T. (2022). Treatment of Opioid Use Disorder in Canadian Psychosocial Addiction Programs: A National Survey of Policy, Attitudes, and Practice. The Canadian Journal of Psychiatry...

Source: Pasman, E., Kollin, R., Broman, M. et al. Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities. Addict Sci Clin Pract 17, 35 (2022). https://doi.org/10.1186/s13722-022-00316-3 Abstract Background Though methadone has been shown to...

Source: Le TT, Park S, Choi M, et al. Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease. BMJ Open Respiratory Research 2020;7:e000483. doi: 10.1136/bmjresp-2019-000483 Abstract Background Opioids and...

Source: Shorter, G. W., Harris, M., McAuley, A., Trayner, K. M., & Stevens, A. (2022). The United Kingdom's first unsanctioned overdose prevention site; A proof-of-concept evaluation. International Journal of Drug Policy, 104, 103670. Abstract Background The United Kingdom (UK) is currently...

Source: Yang Lim, T, et al. (2022). Modeling the evolution of the US opioid crisis for national policy development. Proceedings of the National Academy of Sciences, 119(23). https://www.pnas.org/doi/10.1073/pnas.2115714119 Significance The opioid crisis remains one of the greatest public health...

Source: Heikkinen, M., Taipale, H., Tanskanen, A., Mittendorfer‐Rutz, E., Lähteenvuo, M., & Tiihonen, J. (2022). Real‐world effectiveness of pharmacological treatments of opioid use disorder in a national cohort. Addiction. Abstract Aim To investigate the real-world effectiveness of pharmacological...

Source: Janzow, G. E., Harding, C., Flores, M., Borodovsky, J., Steinkamp, J., Marsch, L. A., & Schuman-Olivier, Z. (2022). Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized...

Source: Romero-Mendoza, M., Peláez-Ballestas, I., Almanza-Avendaño, A.M. et al. Structural violence and the need for compassionate use of methadone in Mexico. BMC Public Health 22, 606 (2022). https://doi.org/10.1186/s12889-022-12955-x Abstract Background Epidemiological data from Mexico have...